From the depths of an economic slump springs the next upcycle.
Introducing Causeway Fiduciary ESG Scores
Causeway has added environmental, social, and governance (“ESG”) scoring to its Risk Lens tool.
Causeway Funds Webcasts: 1Q2022
Causeway Funds invites you to view our 1Q2022 series of quarterly webcasts. During these webcasts, we review performance of our funds and share our investment outlook.
article / April 2022
The Electric Vehicle Transition
Are electric vehicles sounding the death knell for traditional auto manufacturers or are there investment opportunities for value-focused investors?
video / March 2022
Avoiding Disasters in Emerging Markets Equities
Russian stocks appeared extremely cheap. But other components of Causeway's emerging markets alpha model revealed red flags.
webcast / February 2022
Introducing Causeway Global Sustainable Leaders Equity Strategy
Causeway has gone one step further in its ESG journey and developed sustainability-focused investment strategies.
article / February 2022
Goodbye, Value Winter: The Unwinding of Financial Repression
As global liquidity shrinks, valuation should reclaim center stage in equity markets.
webcast / January 2022
Causeway Funds Webcasts: 4Q2021
Causeway Funds invites you to view our 4Q2021 series of quarterly webcasts. During these webcasts, we review performance of our funds and share our investment outlook.
article / November 2021
Covid, Supply Chain, Inflation, Oh My!
Causeway portfolio managers share how they are positioning portfolios amid supply chain disruptions.
webcast / October 2021
Causeway Funds Webcasts: 3Q2021
Causeway Funds invites you to view our 3Q2021 series of quarterly webcasts. During these webcasts, we review performance of our funds and share our investment outlook.
webcast / October 2021
A Value Manager's Take On Disruption: Advancements In Precision Medicine
The emerging practice of precision medicine, the use of genetic or other biomarker information to tailor treatments, has already led to life-changing healthcare breakthroughs for patients fighting cancer and other diseases. We discuss the past, present and future of precision medicine and discuss some of the investment opportunities we are uncovering in this area.